KRT19: A Potential Drug Target for Various Diseases (G3880)

Target Name: KRT19

NCBI ID: G3880

KRT19

KRT19: A Potential Drug Target for Various Diseases

KRT19 (CYFRA 21-1 (cytokeratin-19 fragment)), is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nails. It is a fragment of the cytokeratin gene, which encodes a protein known as cytokeratin-19 (CK-19). CK-19 is a type of transcription factor that is involved in cell growth, differentiation, and repair.

Recent studies have identified KRT19 as a potential drug target in the treatment of various diseases, including cancer, skin diseases, and autoimmune disorders. This is due to its involvement in the regulation of cell growth and differentiation, as well as its role in the development of certain diseases.

One of the key reasons for the potential of KRT19 as a drug target is its location in the genome. KRT19 is located on chromosome 19, which is a gene that is highly conserved across various species. This means that it is unlikely to have many redundant or similar sequences, which can make it a more stable and less prone to errors target for drugs.

Additionally, KRT19 has been shown to play a role in the development and progression of various diseases. For example, studies have shown that KRT19 is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting KRT19 may be a useful way to treat these diseases.

Another potential mechanism by which KRT19 may be targeted for drug treatment is its role in the regulation of cell growth and differentiation. KRT19 is a transcription factor that is involved in the regulation of cell growth by promoting the growth of stem cells and the maintenance of their undifferentiated state. This means that KRT19 may be a useful target for drugs that are designed to inhibit cell growth and prevent the development of cancer.

In addition to its potential role in the regulation of cell growth and differentiation, KRT19 has also been shown to play a role in the development of certain diseases. For example, studies have shown that KRT19 is overexpressed in various autoimmune disorders, such as rheumatoid arthritis and psoriasis. This suggests that targeting KRT19 may be a useful way to treat these disorders.

Overall, KRT19 is a protein that has the potential to be a drug target for the treatment of various diseases. Its location in the genome, its involvement in the regulation of cell growth and differentiation, and its role in the development of certain diseases make it a promising target for drug development. Further research is needed to fully understand the potential of KRT19 as a drug target and to develop safe and effective treatments.

Protein Name: Keratin 19

Functions: Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle

The "KRT19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets